Last update 01 Nov 2024

Foshan Ionova Biotherapeutics Co., Ltd.

Private Company|
2017|
Guangdong Sheng, China
|
www.ionovabio.com

Overview

Tags

Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
EP4(Prostanoid EP4 receptor)1

Related

1
Drugs associated with Foshan Ionova Biotherapeutics Co., Ltd.
INV-1120
Target
EP4
Mechanism
EP4 antagonists [+1]
Active Org.
Foshan Ionova Biotherapeutics Co., Ltd. [+1]
Originator Org.
Ionova Life Science Co., Ltd.Ionova Life Science Co., Ltd.Startup
Active Indication
Metastatic Solid Tumor [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Foshan Ionova Biotherapeutics Co., Ltd.
CTR20211872 / RecruitingPhase 1
INV-1120在局部晚期/转移性实体瘤患者中的首次人体、开放式、I期（剂量递增）临床试验
[Translation] A first-in-human, open-label, Phase I (dose-escalation) clinical trial of INV-1120 in patients with locally advanced/metastatic solid tumors
100 Clinical Results associated with Foshan Ionova Biotherapeutics Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Foshan Ionova Biotherapeutics Co., Ltd.
Login to view more data
100 Deals associated with Foshan Ionova Biotherapeutics Co., Ltd.
Login to view more data
100 Translational Medicine associated with Foshan Ionova Biotherapeutics Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
INV-1120
 ( EP4 )		Metastatic Solid Tumor
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free